Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 3 of 51, showing 5 Applications out of 251 total, starting on record 11, ending on 15

# Protocol No Study Title Investigator(s) & Site(s) Application Status

11.

ECCT/20/07/02   RV 460 HIV Vaccine Trial
    A Randomized, Double-Blind Phase 1 Trial to Evaluate the Safety and Immunogenicity of   Priming with Env-C Plasmid DNA Vaccine Alone, with Different Adjuvants, or with an   Adjuvanted HIV Env gp145 C.6980 Protein Vaccine and Boosting with the Adjuvanted   HIV Env gp145 C.6980 Protein Vaccine with or without the Env-C Plasmid DNA Vaccine   in Healthy HIV Uninfected Adults in Kenya   
Principal Investigator(s)
1. Josphat Kosgei
Site(s) in Kenya
KEMRI/US MRDA-A/K, KERICHO
 
Trial Status Not yet recruiting
Protocol Date 29-02-2020
View

12.

ECCT/20/08/01   CorNeat EverPatch
    The CorNeat EverPatch – A First-In-Human Clinical Study for Demonstrating the Safety of a Synthetic Tissue Substitute for Concealment of Artificial Implants and Glaucoma Tube Shunts       
Principal Investigator(s)
1. Lily Adhiambo Nyamai
Site(s) in Kenya
1. Lions SightFirst Hospital (Nairobi City county)
2. Kenyatta National Hospital (Nairobi City county)
3. Kwale Eye Centre (Kwale county)
 
Trial Status Not yet recruiting
Protocol Date 11-06-2020
View

13.

ECCT/20/06/04   ANTICOV (01 COV)
    An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild /moderate cases of COVID-19   
Principal Investigator(s)
1. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Mbagathi Infectious Disease Hospital (Nairobi City county)
2. Kenyatta University Teaching, Referral and Research Hospital (Nairobi City county)
 
Trial Status Not yet recruiting
Protocol Date 16-06-2020
View

14.

ECCT/20/07/01   Convalescent plasma trial
    A randomized control trial comparing convalescent plasma therapy plus standard treatment versus standard treatment alone in patients with severe COVID-19 pneumonia at a tertiary hospital   
Principal Investigator(s)
1. Dr Isaac Adembesa Kadambi
Site(s) in Kenya
Kenyatta University Teaching Referral and Research Hospital
 
Trial Status (not set!)
Protocol Date 12-09-2020
View

15.

ECCT/20/06/03   CVIA078
    A Phase 2b randomized, open-label, controlled, single center study in Plasmodium falciparum-infected and uninfected adults age 18-55 years old in Kenya to evaluate the efficacy of the delayed, fractional dose RTS,S/AS01E malaria vaccine in subjects treated with artemisinin combination therapy plus primaquine   
Principal Investigator(s)
1. Nathanial Kelsey Copeland
Site(s) in Kenya
Kombewa Clinical Research Centre
 
Trial Status Recruiting
Protocol Date 14-05-2020
View